Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00441246Phase 4Completed
A Phase 4 trial of guaifenesin + pseudoephedrine hydrochloride in Acute Respiratory Infection (ARI), sponsored by Adams Respiratory Therapeutics. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00441246.